NLS Pharmaceutics (NLSP) said Friday that Kadimastem's shareholders have approved the company's merger with NLS.
NLS said it is also planning to hold a shareholder meeting for final approval of the deal.
NLS shares were up 45% in recent trading.
Price: 2.88, Change: +0.90, Percent Change: +45.45
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.